Imatinib Completed Phase N/A Trials for Urticaria Pigmentosa / Chronic Myeloid Leukemia (CML) / Hypereosinophilic Syndromes / Chronic Myelomonocytic Leukemia / Polycythemia Vera (PV) Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00038675Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate